# EDGAR Filing Document

**Accession Number:** 0000883241
**File Stem:** 0001822289-25-000008
**Filing Date:** 2025-12
**Character Count:** 13983
**Document Hash:** 952a9881e94d4984ae3d0499c9747dfa
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001822289-25-000008.hdr.sgml**: 20251218

**ACCESSION NUMBER**: 0001822289-25-000008

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 4

**CONFORMED PERIOD OF REPORT**: 20251216

**FILED AS OF DATE**: 20251218

**DATE AS OF CHANGE**: 20251218

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Ghazi Sassine
- **CENTRAL INDEX KEY:** 0001822289

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-19807
- **FILM NUMBER:** 251584599

**MAIL ADDRESS:**
- **STREET 1:** 3075 W RAY ROAD, SUITE 528
- **STREET 2:** THE PARK AT SAN TAN
- **CITY:** CHANDLER
- **STATE:** AZ
- **ZIP:** 85226
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SYNOPSYS INC
- **CENTRAL INDEX KEY:** 0000883241
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 561546236
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1031

**BUSINESS ADDRESS:**
- **STREET 1:** 675 ALMANOR AVE
- **CITY:** SUNNYVALE
- **STATE:** CA
- **ZIP:** 94085
- **BUSINESS PHONE:** 6505845000

**MAIL ADDRESS:**
- **STREET 1:** 675 ALMANOR AVE
- **CITY:** SUNNYVALE
- **STATE:** CA
- **ZIP:** 94085

## Ex-24

```

SYNOPSYS, INC.
POWER OF ATTORNEY

The undersigned hereby constitutes and appoints each of John F. Runkel, Jr.,
Erika Varga McEnroe, Derek Chien, Dipika Lakhmani, Liz Ramirez, and Anna Felix;
each acting individually, as his/her true and lawful attorney-in-fact to:

(1)   prepare, execute in the undersigned's name and on the undersigned's
behalf, and submit to the U.S. Securities and Exchange Commission
(the "SEC") a Form ID, including amendments thereto, and any other
documents necessary or appropriate to obtain codes and passwords
enabling the undersigned to make electronic filings with the SEC of
reports required by Section 16(a) of the Securities Exchange Act of 1934,
as amended, and the rules and regulations promulgated thereunder
(the "Exchange Act"), or any rule or regulation of the SEC;

(2)	execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer or director of the Company, any
and all Initial Statements of Beneficial Ownership of Securities on Form 3,
Statements of Change of Beneficial Ownership of Securities on Form 4 and
Annual Statements of Beneficial Ownership of Securities on Form 5 (including
amendments thereto) in accordance with Section 16(a) of the
Exchange Act;

(3)	execute for and on behalf of the undersigned Form 144 (including
amendments thereto), in accordance with Rule 144 under the Securities Act
of 1933, as amended, and the rules and regulations promulgated thereunder
(the "Securities Act");

(4)	execute for and on behalf of the undersigned Schedule 13D or
Schedule 13G (including amendments thereto) in accordance with Sections 13(d)
and 13(g) of the Exchange Act, and Form 13F or Form 13H
(including amendments thereto) in accordance with Sections 13(f) and
13(h) of the Exchange Act;

(5)	do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and
execute any such form, schedule or other documentation pursuant
to the Securities Act and/or Exchange Act, including, but not limited to,
Form ID, Form 3, Form 4, Form 5, Form 144, Schedule 13D,
Schedule 13G, Form 13F or Form 13H (including any amendments thereto)
(such Forms and Schedules, "Required Documentation")
and timely file such report with the SEC and any stock exchange,
stock market or similar authority; and

(6)	take any other action of any type whatsoever in connection with
the foregoing that, in the opinion of such attorney-in-fact, may be
of benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned, pursuant to this
Power of Attorney, shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in his/her
discretion.

The undersigned hereby grants to such attorney-in-fact full power
and authority to do and perform all and every act and thing whatsoever
requisite, necessary, and proper to be done in the
exercise of any of the rights and powers herein granted, as fully to
all intents and purposes as the undersigned might or could do if
personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact,
or his/her substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers
herein granted. The undersigned acknowledges that no such
attorney-in-fact, in serving in such capacity at the
request of the undersigned, is hereby assuming, nor is the Company hereby
assuming, any of the undersigned's responsibilities
to comply with Section 16, Sections 13(d) and 13(g) or Sections 13(f)
and 13(h) of the Exchange Act or Rule 144 under the Securities Act.

	This Power of Attorney shall supersede and revoke any Power of Attorney
previously executed with respect to any Required Documentation and shall
remain in full force and effect until the undersigned is no longer required
to file such Required Documentation, unless earlier revoked by the undersigned
in a signed writing delivered to the foregoing attorney-in-fact.

		IN WITNESS WHEREOF, the undersigned has caused this
Power of Attorney to be executed as of this 28th day of March, 2023.

	/s/ Sassine E. Ghazi
	Sassine E. Ghazi

```

## Ex-24

```

SYNOPSYS, INC.
SUBSTITUTE POWER OF ATTORNEY

Pursuant to written powers of attorney (each a "Power of Attorney") by the
Individuals listed below, the undersigned, Liz Ramirez, has been constituted
and appointed the lawful attorney-in-fact and agent of the individuals, with
full power of substitution, to execute and file documents with the U.S.
Securities and Exchange Commission pursuant to Sections 13(d), 13(g), 13(f),
13(h) and 16(a) of the Securities Exchange Act of 1934, as amended, and Rule
144 of the Securities Act of 1933, as amended, with respect to equity securities
of Synopsys, Inc. and with such further powers as specified in each Power of
Attorney.

Individual			Date of Power of Attorney
Luis Borgen			March 20, 2023
Janice Chaffin			March 21, 2023
Bruce Chizen			March 21, 2023
Aart de Geus			March 20, 2023
Sassine Ghazi			March 20, 2023
Shelagh Glaser			March 20, 2023
Mercedes Johnson		March 20, 2023
Sudhindra Kankanwadi		April 3, 2023
Robert G. Painter		July 28, 2023
Jeannine Sargent		March 20, 2023
John Schwarz			March 19, 2023

In accordance with the authority granted under each Power of Attorney, including
the power of substitution, the undersigned hereby appoints Mary Lai as a
substitute attorney-in-fact, on behalf of the individuals listed above, with the
full power of substitution, to exercise and execute all of the powers granted or
conferred to the undersigned in each Power of Attorney.

For the avoidance of doubt, the foregoing appointment shall not serve as a
revocation of the powers granted to the undersigned herself in each Power of
Attorney.

This Substitute Power of Attorney shall remain in full force and effect unless
and until revoked by the undersigned.

IN WITNESS WHEREOF, the undersigned has caused this Substitute Power of Attorney
to be executed as of December 11, 2025.

/s/ Liz Ramirez
Liz Ramirez

```

## Ex-24

```

SYNOPSYS, INC.
SUBSTITUTE POWER OF ATTORNEY

Pursuant to written powers of attorney (each a "Power of Attorney") by the
Individuals listed below, the undersigned, Anna Felix, has been constituted
and appointed the lawful attorney-in-fact and agent of the individuals, with
full power of substitution, to execute and file documents with the U.S.
Securities and Exchange Commission pursuant to Sections 13(d), 13(g), 13(f),
13(h) and 16(a) of the Securities Exchange Act of 1934, as amended, and Rule
144 of the Securities Act of 1933, as amended, with respect to equity securities
of Synopsys, Inc. and with such further powers as specified in each Power of
Attorney.

Individual			Date of Power of Attorney
Luis Borgen			March 20, 2023
Janice Chaffin			March 21, 2023
Bruce Chizen			March 21, 2023
Aart de Geus			March 20, 2023
Sassine Ghazi			March 20, 2023
Shelagh Glaser			March 20, 2023
Mercedes Johnson		March 20, 2023
Sudhindra Kankanwadi		April 3, 2023
Robert G. Painter		July 28, 2023
Jeannine Sargent		March 20, 2023
John Schwarz			March 19, 2023

In accordance with the authority granted under each Power of Attorney, including
the power of substitution, the undersigned hereby appoints Anthony Mawla as a
substitute attorney-in-fact, on behalf of the individuals listed above, with the
full power of substitution, to exercise and execute all of the powers granted or
conferred to the undersigned in each Power of Attorney.

For the avoidance of doubt, the foregoing appointment shall not serve as a
revocation of the powers granted to the undersigned herself in each Power of
Attorney.

This Substitute Power of Attorney shall remain in full force and effect unless
and until revoked by the undersigned.

IN WITNESS WHEREOF, the undersigned has caused this Substitute Power of Attorney
to be executed as of December 11, 2025.

/s/ Anna Felix
Anna Felix

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Ghazi Sassine<br><sub>(Last) (First) (Middle)</sub><br>675 ALMANOR AVENUE<br><sub>(Street)</sub><br>SUNNYVALE, CA 94085<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-12-16 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_PRESIDENT AND CEO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>SYNOPSYS INC [ SNPS ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | $0.0 | 2025-12-16 |  | A<sup>(1)</sup> |  | 19856 |  | 2026-06-15<sup>(2)</sup> | 2028-12-15 | Common Stock | 19856 | $0.0 | 19856 | D |  |

---

### Footnotes:

(1) The Compensation Committee of the Board of Directors approved a restricted stock unit grant under the Synopsys, Inc. 2006 Employee Equity Incentive Plan.

(2) One-sixth (1/6) of the units vest on the date shown followed by five equal semi-annual installments, subject to continued service through each vesting date.

**Signature:** By: POA pursuant Mary Lai For: Sassine E Ghazi  
**Date:** 2025-12-18

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**